Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06236581 · ClinicalTrials.gov registry record · NA
Glycemic Excursion Minimization (GEM) to Outshine Health Disparities
A NA study of Type 2 Diabetes, sponsored by Catherine Davis.
- Recruiting
- Registry status
- NA
- Development phase
- 25
- Enrollment target
- 1
- Study location
NCT06236581: Recruiting NA study of Type 2 Diabetes, sponsored by Catherine Davis.
NCT06236581 is a NA study of Type 2 Diabetes that is actively recruiting participants, run by Catherine Davis. The registered enrollment target is 25 participants, below the 1,103-participant average among 288 other Type 2 Diabetes trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06236581, a NA study of Type 2 Diabetes, is actively recruiting participants, sponsored by Catherine Davis.
- RECRUITING
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to see if the GEM intervention is acceptable and helpful to Black adults with type 2 diabetes. The GEM intervention (coaching to reduce carbohydrate intake and increase physical activity after meals, with feedback from a continuous glucose monitor, CGM) might improve blood glucose levels, reduce diabetes distress, and increase empowerment and confidence in managing diabetes.
Conditions Studied
Interventions
- BEHAVIORAL GEM Intervention
Study Locations (1)
Georgia
- Georgia Prevention Institute - Augusta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2024-06-20 |
| Est. Completion | 2024-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06236581
The ClinicalTrials.gov registry entry for NCT06236581 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,103-participant average among 288 other Type 2 Diabetes trials with a reported enrollment target (98% lower). The listed sponsor is Catherine Davis, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Type 2 Diabetes appearing as the primary indexed condition, and to 1 intervention - of which GEM Intervention is the first listed.
NCT06236581 reports 1 study location spanning 1 distinct geographic area - top geographies include Georgia.
Frequently Asked Questions
What is clinical trial NCT06236581 about?
NCT06236581 is a clinical study titled "Glycemic Excursion Minimization (GEM) to Outshine Health Disparities". The purpose of this study is to see if the GEM intervention is acceptable and helpful to Black adults with type 2 diabetes. The GEM intervention (coaching to reduce carbohydrate intake and increase physical activity after meals, with feedback from a continuous glucose monitor, CGM) might improve blo...
What is the current status of trial NCT06236581?
This trial is currently recruiting. It is a NA study. The enrollment target is 25 participants. The study started on 2024-06-20. Estimated completion is 2024-12.
What conditions does trial NCT06236581 study?
This clinical trial studies the following conditions: Type 2 Diabetes.
What interventions are being tested in trial NCT06236581?
The interventions under investigation include: GEM Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT06236581?
This trial is sponsored by Catherine Davis, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06236581 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Type 2 Diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Enhancing Telemedicine for T2D
RECRUITING · NA
-
Sleep and Glycemic Control in Type 2 Diabetes Adolescents
RECRUITING · NA
-
Enhancing Preventative Health Behaviors Among Emergency Department Hyperglycemic Patients
RECRUITING · NA
-
Ultrasound Effects on Glycemic Control in T2DM
RECRUITING · NA
-
A Randomized Double-Blinded and Placebo-Controlled Trial to Assess the Efficacy of Biophoton Therapy to Treat Type 2 Diabetes
RECRUITING · NA
-
High Fructose Diet, the Gut Microbiome, and Metabolic Health
RECRUITING · NA
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.